Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

Overview of attention for article published in Investigational New Drugs, July 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 32 patents

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 32 patents that reference this research output.

Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

About this Attention Score

Mentioned by

Citations

Readers on

Compositions and methods for CD20 immunotherapy

Grant US-11834511-B2

United States of America

Antibodies, variable domains and chains tailored for human use

Grant US-11820810-B2

United States of America

Animal models and therapeutic molecules

Grant US-11812731-B2

United States of America

Animals, repertoires and methods

Grant US-11707056-B2

United States of America

Binding molecules with modified J-chain

Grant US-11639389-B2

United States of America

Animal models and therapeutic molecules

Grant US-11606941-B2

United States of America

Animal models and therapeutic molecules

Grant US-11564380-B2

United States of America

Modified J-chain

Grant US-11555075-B2

United States of America

Binding molecules with modified J-chain

Grant US-11542342-B2

United States of America

CD20 antibodies

Grant US-11414495-B2

United States of America

Animal models and therapeutic molecules

Grant US-11399522-B2

United States of America

Transgenic non-human vertebrate for the expression of class-switched, fully human…

Grant US-11297811-B2

United States of America

Methods for selective expansion of γδ T-cell populations and compositions thereof

Grant US-11299708-B2

United States of America

Animal models and therapeutic molecules

Grant US-11297810-B2

United States of America

Engineered γδ T-cells

Grant US-11135245-B2

United States of America

Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics

Grant US-11051497-B2

United States of America

Modified J-chain

Grant US-10975147-B2

United States of America

Compositions and methods for CD20 immunotherapy

Grant US-10875927-B2

United States of America

Multimeric bispecific binding molecules specific for CD20 and CD3

Grant US-10787520-B2

United States of America

Animal models and therapeutic molecules

Grant US-10774155-B2

United States of America

Antibodies, variable domains and chains tailored for human use

Grant US-10730930-B2

United States of America

Transgenic non-human vertebrate for the in vivo production of dual specificity…

Grant US-10667501-B2

United States of America

Transgenic non-human vertebrate for the expression of class-switched, fully human…

Grant US-10251377-B2

United States of America

Animal models and therapeutic molecules

Grant US-10226033-B2

United States of America

Animal models and therapeutic molecules

Grant US-10165763-B2

United States of America